Exenatide Exenatide (Byetta), an incretin mimetic, is FDA approved for use as adjunctive therapy in patients whose T2DM is inadequately controlled with metformin, an SU, a TZD, or with combination of metformin plus an SU or TZD
Patients should be advised to maintain adequate hydration and report severe or persistent symptoms promptly
Journal paper reviewed in full
If you are interested in exploring medical weight loss treatments, contact Pine Point Medical today to schedule a consultation and discuss which approach may align best with your goals
High-Protein Whole Grains Protein neednt always come from animal sources or protein powders
You may also experience a significant loss of appetite, feeling full after just a few bites